Valerie Agena, DO
Geriatric Medicine · Fort Worth, TXNPI 1669498481
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $443 and has fallen 66.4% since, to $149 in 2025.
Across 26 payments — averaging $45.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$203
- Shockwave Medical, Inc$149
- Abiomed$143
- Amarin Pharma, Inc.$125
- AstraZeneca$125
- Medtronic$124
- plus $310 from 7 others
What the payments were for
- Food & beverage$1,179100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 10 | $203 |
| Shockwave Medical, Inc | 1 | $149 |
| Abiomed | 1 | $143 |
| Amarin Pharma, Inc. | 1 | $125 |
| AstraZeneca | 1 | $125 |
| Medtronic | 1 | $124 |
| Pfizer | 1 | $120 |
| Biogen | 4 | $70 |
| Sunovion Pharmaceuticals Inc. | 1 | $44 |
| Novartis | 2 | $25 |
| UCB, Inc. | 1 | $19 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Radius Health, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,179 in reported general payments places this provider in the 75th percentile of 275 geriatric medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amlodipine Besylate | 18 | $318 |
| Metoprolol Succinate | 11 | $315 |
| Sertraline Hcl | 14 | $244 |
Paid to pharmacies, not to this prescriber.
Other geriatric medicine in Fort Worth
- Ryan ChoudhuryFort Worth$4K
- Sarah RossFort Worth$2K
- Melissa HudsonFort Worth$2K
- Brittany LoveFort Worth$2K
- Mauricio Gonzalez-AriasAustin$825K
- Eberenne IgbokwePearland$124K
- Diana KerwinDallas$81K
- David SmithBrownwood$19K
- Alejandro ArizmendiHelotes$15K
- Rosa VizcarraSan Antonio$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.